These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 14065992)

  • 1. DIETARY TREATMENT OF A CHILD WITH MAPLE SYRUP URINE DISEASE (BRANCHED-CHAIN KETOACIDURIA).
    WESTALL RG
    Arch Dis Child; 1963 Oct; 38(201):485-91. PubMed ID: 14065992
    [No Abstract]   [Full Text] [Related]  

  • 2. [MAPLE SYRUP URINE DISEASE].
    TIMMERMANS J
    Maandschr Kindergeneeskd; 1963 Oct; 31():337-47. PubMed ID: 14100237
    [No Abstract]   [Full Text] [Related]  

  • 3. MAPLE-SYRUP-URINE DISEASE. REPORT OF A CASE, WITH A PEDIGREE.
    LONSDALE D; BARBER DH
    N Engl J Med; 1964 Dec; 271():1338-41. PubMed ID: 14214646
    [No Abstract]   [Full Text] [Related]  

  • 4. MAPLE SYRUP URINE DISEASE.
    SNYDERMAN SE; HOLT LE
    J Maine Med Assoc; 1964 Jan; 55():3-5. PubMed ID: 14109847
    [No Abstract]   [Full Text] [Related]  

  • 5. LATE MANIFESTING VARIANT OF BRANCHED-CHAIN KETOACIDURIA (MAPLE SYRUP URINE DISEASE).
    KIIL R; ROKKONES T
    Acta Paediatr (Stockh); 1964 Jul; 53():356-64. PubMed ID: 14184314
    [No Abstract]   [Full Text] [Related]  

  • 6. [CLINICAL, BIOCHEMICAL, AND NEUROPATHOLOGIC ASPECTS OF MAPLE SYRUP URINE DISEASE. A KETOACIDURIA OF THE OPEN CHAIN AMINOACIDS LEUCINE, ISOLEUCINE AND VALINE].
    SILBERMANSCHWARTZMAN J
    An Fac Med Lima; 1963 Sep; 46():339-65. PubMed ID: 14122039
    [No Abstract]   [Full Text] [Related]  

  • 7. MAPLE SYRUP URINE DISEASE, WITH PARTICULAR REFERENCE TO DIETOTHERAPY.
    SNYDERMAN SE; NORTON PM; ROITMAN E; HOLT LE
    Pediatrics; 1964 Oct; 34():454-72. PubMed ID: 14212461
    [No Abstract]   [Full Text] [Related]  

  • 8. Leucine equivalency system in managing branched chain ketoaciduria.
    Smith BA; Waisman HA
    J Am Diet Assoc; 1971 Oct; 59(4):342-6. PubMed ID: 5095277
    [No Abstract]   [Full Text] [Related]  

  • 9. THE DIAGNOSIS OF MAPLE SYRUP URINE DISEASE (BRANCHED- CHAIN KETOACIDURIA) BY THE IN VITRO STUDY OF THE PERIPHERAL LEUKOCYTE.
    DANCIS J; HUTZLER J; LEVITZ M
    Pediatrics; 1963 Aug; 32():234-8. PubMed ID: 14044451
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the clinical picture and pathological anatomy of the maple syrup disease ("branded chain ketoaciduria"). Report on 2 cases in 1 family].
    Sander C; Clotten R; Noetzel H; Wehinger H
    Dtsch Med Wochenschr; 1968 May; 93(18):895-903 passim. PubMed ID: 5650843
    [No Abstract]   [Full Text] [Related]  

  • 11. [Maple syrup urine disease. (Valine-leucine-uria)].
    Platt D; Beneke G; Peiffer J; Schmidt GW
    Med Welt; 1966 May; 19():1089-93. PubMed ID: 5974899
    [No Abstract]   [Full Text] [Related]  

  • 12. A new variant of maple syrup urine disease (branched chain ketoaciduria). Clinical and biochemical evaluation.
    Schulman JD; Lustberg TJ; Kennedy JL; Museles M; Seegmiller JE
    Am J Med; 1970 Jul; 49(1):118-24. PubMed ID: 5431474
    [No Abstract]   [Full Text] [Related]  

  • 13. MAPLE SYRUP URINE DISEASE: A MANIFESTATION OF AN UNUSUAL METABOLIC ERROR.
    DANCIS J
    Clin Pediatr (Phila); 1964 Jun; 3():365-7. PubMed ID: 14154327
    [No Abstract]   [Full Text] [Related]  

  • 14. [Acrodermatitis enteropathica-like syndrome secondary to branched-chain amino acid deficiency during treatment of maple syrup urine disease].
    Templier I; Reymond JL; Nguyen MA; Boujet C; Lantuejoul S; Beani JC; Leccia MT
    Ann Dermatol Venereol; 2006 Apr; 133(4):375-9. PubMed ID: 16733455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MAPLE SYRUP URINE DISEASE.
    VOYCE MA; MONTGOMERY JN; LYNCH GA; BOWMAN JK
    Br Med J; 1964 May; 1(5393):1293. PubMed ID: 14123637
    [No Abstract]   [Full Text] [Related]  

  • 16. Maple syrup urine disease. Four years' experience with dietary treatment of a case.
    Dickinson JP; Holton JB; Lewis GM; Littlewood JM; Steel AE
    Acta Paediatr Scand; 1969 Jul; 58(4):341-51. PubMed ID: 5824823
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma amino acid analyses in two cases of maple syrup urine disease.
    Surarit R; Srisomsap C; Wasant P; Svasti J; Suthatvoravut U; Chokchaichamnankit D; Liammongkolkul S
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():138-9. PubMed ID: 11400750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semiquantitation of leucine, isoleucine, and valine by thin-layer chromatography in management of maple-syrup urine diseases.
    Allen RJ; Frey HJ; Fleming LM; Owings CL
    Clin Chem; 1972 May; 18(5):413-6. PubMed ID: 5019114
    [No Abstract]   [Full Text] [Related]  

  • 19. The therapy of maple syrup urine disease.
    Snyderman SE
    Am J Dis Child; 1967 Jan; 113(1):68-73. PubMed ID: 6015908
    [No Abstract]   [Full Text] [Related]  

  • 20. The need of essential amino acids in children. An evaluation based on the intake of phenylalanine, tyrosine, leucine, isoleucine, and valine in children with phenylketonuria, tyrosine amino transferase defect, and maple syrup urine disease.
    Kindt E; Halvorsen S
    Am J Clin Nutr; 1980 Feb; 33(2):279-86. PubMed ID: 6101930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.